genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Medical oncology
Cancer
Positive Phase II Bolsters Aura Bioscience’s Confidence in VDC-based Therapy for Ocular Melanomas
Cancer
Democratizing Precision Medicine
Cancer
Stem Cell Model Illuminates Genetic Drivers of Neuroblastoma
Cancer
3D-Printed Tumors Replicate Biopsies of Cancer Patients
Drug Discovery
Maximizing Efficacy in Immuno-Oncology Drug Development
Cancer
Cancer Genomics Aims to See All, Know All, Inform All
Featured
Brain Organoids from Fetal Tissue Take CRISPR Changes, Enable Tumor Modeling
Artificial Intelligence
Salt Burn: NFX and Merck Seed Pepper Bio to Develop Drugs with Transomics
Best Apps
SITC Guidelines
Cancer
6 Immuno-oncology Startups Attracting the Biggest VC Cash
1
2
3
...
84
Page 1 of 84
Scroll Up
Scroll Up
